Research Topics
Genomes and GenesSpecies | Jeffrey H MeyerSummaryAffiliation: Centre for Addiction and Mental Health Country: Canada Publications
| Collaborators
|
Detail Information
Publications
The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging studyJ H Meyer
Clarke Division, Centre for Addictions and Mental Health, Department ofPsychiatry, University of Toronto, Ontario, Canada
Am J Psychiatry 158:78-85. 2001..The objective of this study was to evaluate the effect of 6 weeks of paroxetine treatment on 5-HT(2A) receptors in depressed patients...
Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging studyJ H Meyer
PET Centre, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Ontario, Canada
Am J Psychiatry 158:1843-9. 2001..This study measured the proportion of 5-HTT sites blocked during paroxetine and citalopram treatment of depression and assessed the relationship between serum paroxetine levels and the proportion of 5-HTT sites blocked...
Bupropion occupancy of the dopamine transporter is low during clinical treatmentJeffrey H Meyer
Department of Psychiatry, PET Centre, Centre for Addiction and Mental Health, University of Toronto, 250 College Street, Toronto, Ontario M5T 1R8, Canada
Psychopharmacology (Berl) 163:102-5. 2002..The validity of this mechanism has been questioned because the affinity of bupropion for the DAT is quite low...
Dysfunctional attitudes and 5-HT2 receptors during depression and self-harmJeffrey H Meyer
Vivian M Rakoff PET Imaging Centre, Clarke Division, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College St, Toronto, ON, M5T 1R8, Canada
Am J Psychiatry 160:90-9. 2003....
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography studyJeffrey H Meyer
Clarke Site, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, 250 College St, Toronto, Ont M5T 1R8, Canada
Am J Psychiatry 161:826-35. 2004..The relationship between dose and occupancy was also investigated...
Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrenceJeffrey H Meyer
Vivian M Rakoff PET Imaging Centre, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario M5T 1R8, Canada
Arch Gen Psychiatry 66:1304-12. 2009..The relationship between MAO-A levels and selective serotonin reuptake inhibitor (SSRI) treatment, recovery, and recurrence in MDD is unknown...
Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography studyJulia Sacher
Vivian M Rakoff PET Imaging Centre, Toronto, Canada
J Cereb Blood Flow Metab 32:443-6. 2012..007). These findings suggest an adaptive role for MAO-A in maintaining monoamine neurotransmitter homeostasis by rapidly compensating fluctuating monoamine levels...
Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depressionJeffrey H Meyer
Vivian M Rakoff PET Imaging Centre and Mood and Anxiety Disorders Division, Clarke Division, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Arch Gen Psychiatry 63:1209-16. 2006..Monoamine oxidase A (MAO-A) is an enzyme that metabolizes monoamines, such as serotonin, norepinephrine, and dopamine...
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomographyAristotle N Voineskos
Clarke Site, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, ON, M5T 1R8, Canada
Psychopharmacology (Berl) 193:539-45. 2007..11)C]N,N-dimethyl-2-(2-amino-4-cyanophenylthio) benzylamine positron emission tomography ([(11)C]DASB PET) is currently the best method available to quantify 5-HTT occupancy in humans...
[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in catsNathalie Ginovart
PET Centre, Centre for Addiction and Mental Health and University of Toronto, Toronto, Ontario M5T 1R8, Canada
Synapse 47:123-33. 2003..These studies indicate that [(11)C]-DASB is a suitable PET radioligand for measuring drug occupancy of the SERT in vivo and has potential for monitoring in vivo changes in serotonin levels...
Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudesJeffrey H Meyer
Vivian M Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada
Arch Gen Psychiatry 61:1271-9. 2004..Our recent publication of increased serotonin2 BP in MDE with severely negativistic dysfunctional attitudes suggests that this subgroup of MDE subjects has very low levels of extracellular serotonin...
Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography studyNicole Praschak-Rieder
Vivian M Rakoff Positron Emission Tomography Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada
Biol Psychiatry 62:327-31. 2007..We examined the possible influence of the long (A/G) variant on 5-HTT density in the living human brain using 3-(11)C-amino-4-(2-dimethylaminomethylphenyl-sulfanyl) benzonitrile ([(11)C]DASB) positron emission tomography...
Effects of tryptophan depletion on the serotonin transporter in healthy humansNicole Praschak-Rieder
Vivian M. Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, Canada
Biol Psychiatry 58:825-30. 2005....
Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET studyJulia Sacher
Vivian M Rakoff PET Imaging Centre, University of Toronto, Toronto, Ont
J Psychiatry Neurosci 36:375-82. 2011..John's wort, an herb purported to have MAO-A inhibitor properties...
Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography studyJeffrey H Meyer
College Clarke Site, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, 250 College St, Toronto, Ontario M5T 1R8, Canada
Am J Psychiatry 163:1594-602. 2006..It was hypothesized that putamen D(2) binding potential would be higher during major depressive episodes featuring motor retardation...
Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smokingIngrid Bacher
Vivian M Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, 250 College St, Toronto, ON, Canada
Arch Gen Psychiatry 68:817-26. 2011..Dysphoria during cigarette withdrawal predicts relapse. It is unknown whether MAO-A binding increases during early cigarette withdrawal...
Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASBIsabelle Boileau
Human Neurochemical Pathology Laboratory, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
Mov Disord 23:1776-80. 2008....
Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography studyNicole Praschak-Rieder
Vivian M. Rakoff PET Imaging Centre and the Mood and Anxiety Disorders Division, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Biol Psychiatry 56:587-91. 2004..Therefore, greater consideration must be given to other mechanisms that involve vulnerability to small perturbations in extracellular 5-HT, such as impairment of signal transduction...
Elevated brain monoamine oxidase A binding in the early postpartum periodJulia Sacher
Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario M5T 1R8, Canada
Arch Gen Psychiatry 67:468-74. 2010..However, MAO-A levels have never been measured in the early postpartum period...
Development of new radiopharmaceuticals for imaging monoamine oxidase BNeil Vasdev
PET Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada M5T 1R8
Nucl Med Biol 38:933-43. 2011....
Synthesis and preliminary evaluation of [(18)F]-fluoro-(2S)-Exaprolol for imaging cerebral beta-adrenergic receptors with PETKarin A Stephenson
Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario M5T 1R8, Canada
Neurochem Int 53:173-9. 2008..These results indicate that [(18)F]-(2S)-1 is not a suitable candidate for PET imaging of cerebral beta-ARs...
Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brainNathalie Ginovart
PET Centre, Centre for Addiction and Mental Health, Toronto, Canada
J Cereb Blood Flow Metab 26:330-44. 2006..These results indicate the suitability of using [(11)C]-harmine for quantitative evaluation of MAO-A densities using PET and should enable further studies of potential MAO-A dysregulation in several psychiatric and neurologic illnesses...
Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?Stephen J Kish
Human Neurochemical Pathology Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada M5T 1R8
Nucl Med Biol 32:123-8. 2005..However, there has been no consistency in the selection of a "SERT-free" reference region for the estimation of free and nonspecific binding, as occipital cortex, cerebellum and white matter have all been employed...
Serotonin2A receptor binding potential in people with aggressive and violent behaviourJeffrey H Meyer
Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ont
J Psychiatry Neurosci 33:499-508. 2008..The objective of this study was to investigate prefrontal cortex 5-HT2A binding potential (BPND), an index of 5-HT2A density, in an unbiased sample of people with violent aggressive behaviour...
Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomographyJean N DaSilva
PET Centre, Centre for Addiction and Mental Health, University of Toronto, 250 College Street, Toronto, Ontario, Canada, M5T 1R8
Eur J Nucl Med Mol Imaging 29:1680-3. 2002..R-[(11)C]Rolipram is thus suitable for imaging PDE4 and possibly cAMP signal transduction in the living human brain with PET...
Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomographyPablo M Rusjan
PET Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
J Cereb Blood Flow Metab 31:1807-16. 2011..The excellent identifiability of V(T) values obtained from an unconstrained 2-CM with data from a 2-hour scan support the use of V(T) as an appropriate and feasible outcome measure for [(18)F]-FEPPA...
Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamideNeil Vasdev
Centre for Addiction and Mental Health, 250 College Street, Toronto, Ont, Canada M5T 1R8
Bioorg Med Chem 16:5277-84. 2008..Radioactivity from all excised brain regions was <0.2%ID/g at all time points. The modest brain penetration of [(11)C]5 may limit its use for studying PKA in the central nervous system...
Seasonal variation in human brain serotonin transporter bindingNicole Praschak-Rieder
Vivian M Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, 250 College St, Toronto, ON M5T 1R8, Canada
Arch Gen Psychiatry 65:1072-8. 2008..The serotonin transporter is a key element in regulating intensity and spread of the serotonin signal...
Facile radiosynthesis of fluorine-18 labeled beta-blockers. Synthesis, radiolabeling, and ex vivo biodistribution of [18F]-(2S and 2R)-1-(1-fluoropropan-2-ylamino)-3-(m-tolyloxy)propan-2-olKarin A Stephenson
Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8 Canada
J Med Chem 51:5093-100. 2008..9-1.1 Ci/micromol (EOS). Ex vivo biodistribution studies with the radiotracers demonstrated excessively rapid washout that may limit their use for cerebral PET imaging...
Imaging the serotonin transporter during major depressive disorder and antidepressant treatmentJeffrey H Meyer
Neurochemical Imaging Program in Mood Disorders, PET Centre, Centre for Addiction and Mental Health, Toronto, Ont
J Psychiatry Neurosci 32:86-102. 2007..Implications of 5-HTT imaging findings for understanding major depressive disorder and antidepressant treatment will be discussed...
Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studiesNeil Vasdev
PET Centre, Centre for Addiction and Mental Health, 250 College St, Toronto, Ont, Canada M5T 1R8
Bioorg Med Chem Lett 15:5270-3. 2005..Furthermore, the specific pharmacological mechanism(s) of antidepressant-like activity attributed to AR-A014418 should be investigated...
Applying neuroimaging ligands to study major depressive disorderJeffrey H Meyer
Department of Psychiatry, University of Toronto, Toronto, Canada
Semin Nucl Med 38:287-304. 2008....
PET and SPECT imaging in psychiatric disordersRobert B Zipursky
Department of Psychiatry and Behavioural Neurosciences, Michael G DeGroote School of Medicine, McMaster University, Hamilton, Ontario
Can J Psychiatry 52:146-57. 2007..To review recent findings from positron emission tomography (PET) and single photon emission computed tomography (SPECT) studies that investigate the pathophysiology and treatment of schizophrenia, depression, and dementia...
Misunderstandings about how to choose a reference regionJeffrey H Meyer
Biol Psychiatry 61:1314; author reply 1314-5. 2007
Smoking-induced ventral striatum dopamine releaseArthur L Brody
Veterans Affairs Greater Los Angeles Healthcare, 300 UCLA Medical Plaza, Suite 2200, Los Angeles, CA 90095, USA
Am J Psychiatry 161:1211-8. 2004..The authors used [(11)C]raclopride bolus-plus-continuous-infusion positron emission tomography (PET) to determine smoking-induced ventral striatum dopamine release in humans...
